CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 61 enrolled
Drug / intervention
Tranexamic Aciddrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01728636
NCT01728636Phase 2Completed
CompareCT.gov

The Use of Tranexamic Acid to Reduce Perioperative Blood Loss During High Risk Spine Fusion Surgery

Northwestern University·interventional·Posted Nov 20, 2012·Updated Jan 26, 2021

In Brief

A Phase 2 clinical trial evaluating Tranexamic Acid for Curvature of Spine. Completed, enrolled 61 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if tranexamic acid reduces perioperative blood loss and red blood cell transfusion during high risk spine surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCurvature of Spine
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedNov 20, 2012
Enrollment StartJan 15, 2013
Primary CompletionDec 30, 2017
TodayJul 2, 2026
Enrollment to primary: 5.0 yearsPosted 13.6 years ago

Interventions

Tranexamic Aciddrug

intravenous administration of bolus and infusion for duration of surgical procedure